When Need to Treat Precocious Puberty? New Methods at Treatment – A Talk by Dr. Aygun Musayeva
Introduction
The upcoming 4th
World Pediatrics, Perinatology, and Child Health Summit, scheduled for October 21–23, 2025, at
Novotel Al Barsha, Dubai, UAE, is set to host some of the most
distinguished minds in global pediatric medicine. Among them is Dr.
Aygun Musayeva, a renowned Pediatric
Endocrinologist from Leyla
Medical Center, Azerbaijan, whose dedication to improving children’s
endocrine health continues to inspire both clinicians and researchers
worldwide.
Dr. Musayeva’s presentation, titled “When
Need to Treat Precocious Puberty? New Methods at Treatment,” will
explore one of the most intriguing and challenging topics in pediatric
endocrinology—understanding the delicate balance between physiological
development and premature hormonal activation in children.
Her session aims to highlight emerging
diagnostic markers, genetic discoveries, and innovative therapeutic approaches
that redefine how clinicians approach the treatment of precocious puberty in
the modern era.
A
Glimpse into Precocious Puberty
Precocious puberty, characterized by the early onset of puberty
before the age of 8 in girls and 9 in boys, poses both clinical and
psychological challenges. Beyond its physical manifestations, it can
significantly impact growth potential, emotional well-being, and long-term
health outcomes.
Dr. Musayeva’s expertise sheds light on the importance of timely
diagnosis and individualized management, ensuring that treatment
interventions are scientifically justified rather than reflexive. Her
lecture will discuss modern therapeutic strategies, genetic pathways
such as MKRN3 mutations, and how the neuropeptide regulation of
pubertal onset shapes early puberty cases.
This discussion promises to bring fresh
perspectives and evidence-based
clarity to a field that continues to evolve with each new discovery.
Attendees of Dr.
Musayeva’s session will gain an invaluable opportunity to:
✅ Understand the underlying genetics and physiology behind early
puberty onset.
✅ Differentiate between normal variants and pathological precocious puberty,
ensuring accurate and appropriate treatment decisions.
✅ Discover the role of modern hormonal assays, imaging, and molecular
testing in diagnosis.
✅ Explore new pharmacological options and treatment protocols, including
the latest in GnRH analogs and targeted therapies.
✅ Discuss complex case studies and real-world management strategies,
helping bridge the gap between research and practical application.
✅ Network with global experts, creating collaborative opportunities for
research and innovation in pediatric endocrinology.
For clinicians, researchers, and healthcare providers, Dr. Musayeva’s
lecture offers not just knowledge but actionable insight—a true
highlight of the PediatricsUCG2025 program.
Research
Interests and Academic Pursuits
With a strong academic foundation, Dr.
Aygun Musayeva earned her medical degree from Azerbaijan Medical
University (2011–2017) and completed her pediatric residency (2017–2021)
at the same institution. Currently, she is pursuing a PhD in Pediatric
Endocrinology in Azerbaijan, alongside an MSc in Endocrinology from the
University of South Wales, UK.
Her primary research interests include:
- Central Precocious Puberty
(CPP) – focusing on pathogenesis, genetic mechanisms, and long-term
outcomes.
- MKRN3 mutations and their contribution to
familial forms of CPP.
- Neuropeptide regulation in the timing of puberty
onset.
- Broader aspects of pediatric
endocrine disorders, including growth, thyroid, and adrenal
abnormalities.
Dr. Musayeva’s scholarly contributions—ranging from case studies and
narrative reviews to original research articles—reflect her commitment to
integrating research findings into practical, patient-centered care.
Awards,
Recognition, and Achievements
Throughout her career, Dr.
Musayeva has been recognized for her academic excellence, research
contributions, and clinical leadership. Her studies on precocious puberty
and pediatric hormone regulation have been featured in international
journals, and her participation in scientific conferences across Europe
and Asia has earned her commendation for innovative thinking and
evidence-based insights.
At Leyla
Medical Center, she has played an instrumental role in promoting
advanced diagnostic methods for endocrine disorders, supporting the
implementation of global best practices in Azerbaijan’s pediatric healthcare
landscape.
Her dual focus on research and real-world application makes her
one of the most dynamic figures in the field of pediatric endocrinology today.
Join the
Global Platform – Register Now!
Don’t miss the chance to connect with Dr.
Aygun Musayeva and other global leaders in pediatrics and child health
at this prestigious international summit.
Conference Dates: October 21–23, 2025
Venue: Novotel Al Barsha, Dubai, UAE
Register Here: https://pediatrics.utilitarianconferences.com/registration
Participants will receive access to CME/CPD credits, networking
opportunities, workshops, and interactive sessions covering the latest developments
in pediatric care and child health.
Dr.
Aygun Musayeva’s pioneering work in pediatric
endocrinology exemplifies the spirit of progress in modern child
healthcare. Her research-driven approach to precocious puberty and hormonal
regulation continues to shape the future of diagnosis and therapy in young
patients.
By sharing her expertise at PediatricsUCG2025, Dr. Musayeva not
only contributes to global medical education but also fosters collaboration and
innovation among specialists worldwide. Her commitment to scientific rigor,
patient-centered care, and international cooperation embodies the vision of
a healthier future for children everywhere.
Join this transformative journey in Dubai — where science meets
compassion, and where professionals like Dr. Aygun Musayeva inspire the
next generation of pediatric leaders.
.png)
Comments
Post a Comment